TrialsgrambetaRCTs are beautiful

ECASS III

2008

Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke

In 821 patients with acute ischaemic stroke 3–4.5 h from onset, alteplase improved mRS 0–1 at 90 days versus placebo.

Result

Efficacy: mRS 0–1 at 90 daysOR 1.34 (95% CI 1.02-1.76) · P = 0.04

Below 1 favours placebo, above 1 favours alteplase.

Event rates
Absolute difference
7.2 points
NNT
14

Absolute difference and NNT are derived from the event rates.

Also reported: Symptomatic ICH 2.4% vs 0.2%.

Original publication
Subtopic
IV thrombolysis
Design
Double-blind RCT
Relevance
Practice-defining: a trial the guidelines cite as evidence.
Source
Hacke W, et al. N Engl J Med. 2008;359(13):1317-1329.doi 10.1056/NEJMoa0804656

Discussion & critique

Extended the thrombolysis window to 4.5 h, now standard.

Discussed in podcasts